-
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Average Rating of "Moderate Buy" by Brokerages
Source: Buzz FX / 05 Oct 2024 01:06:12 America/Chicago
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Average Rating of "Moderate Buy" by Brokerages Written by MarketBeat October 5, 2024 Share Link copied to clipboard. Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN - Get Free Report ) has e
Read more...